Abstract:ABSTRACT Osteoclastogenesis is essential for bone remodeling and normal skeletal maintenance. Receptor activator of NF-κB ligand (RANKL) promotes osteoclast differentiation and function but requires costimulation of immunoreceptor tyrosine-based activation motif (ITAM)-coupled immunoreceptors. Triggering receptor expressed on myeloid cells-2 (TREM2) coupled to ITAM-adaptor protein DNAX activation protein 12kDA (DAP12) provides costimulation of intracellular calcium signaling during osteoclastogenesis. Previously, we found that downstream of kinase-3 (DOK3) physically associates with DAP12 to inhibit toll-like receptor (TLR)-induced inflammatory signaling in macrophages. However, whether and how DOK3 modulates DAP12-dependent osteoclastogenesis is unknown and the focus of this study. Bone microarchitecture and histology of sex- and age-matched wild-type (WT) and DOK3-deficient (DOK3-/-) mice were evaluated. Male and female DOK3-/- mice have significantly reduced trabecular bone mass compared with WT mice with increased TRAP+ osteoclasts in vivo. In vitro, DOK3-/- bone marrow-derived macrophages (BMMs) have increased macrophage colony-stimulating factor (M-CSF)-induced proliferation and increased sensitivity to RANKL-induced osteoclastogenesis. Compared with WT, DOK3-/- osteoclasts are significantly larger with more nuclei and have increased resorptive capacity. Mechanistically, DOK3 limits osteoclastogenesis by inhibiting activation of Syk and ERK in response to RANKL and M-CSF. DOK3 is phosphorylated in a DAP12-dependent manner and associates with Grb2 and Cbl. Compared with DAP12-/- mice with high bone mass, DOK3- and DAP12- doubly deficient mice (DKO) have normalized bone mass, indicating that DOK3 also limits DAP12-independent osteoclastogenesis in vivo. In vitro osteoclasts derived from DKO mice are mononuclear with poor resorptive capacity similar to DAP12-/- osteoclasts. Histomorphometry reveals that DOK3-/-mice also have reduced osteoblast parameters. DOK3-/- osteoblasts have reduced in vitro osteoblastogenesis and increased osteoprotegerin (OPG) to RANKL expression ratio compared with WT osteoblasts. Co-culture of WT and DOK3-/- osteoblasts with pre-osteoclasts reveals a reduced capacity of DOK3-/- osteoblasts to support osteoclastogenesis. These data indicate that DOK3 regulates bone remodeling by negatively regulating M-CSF- and RANKL-mediated osteoclastogenesis and positively regulating osteoblastogenesis. © 2017 American Society for Bone and Mineral Research.

DLX3 Negatively Regulates Osteoclastic Differentiation Through Microrna-124

DLX3 Promotes Bone Marrow Mesenchymal Stem Cell Proliferation Through H19/miR-675 Axis

DLX3 Regulates Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Via Wnt/β-catenin Pathway Mediated Histone Methylation of DKK4.

DLX3 (Q178R) Mutation Delays Osteogenic Differentiation Via H19/miR-29c-3p/KDM5B Axis in TDO-iPSCs-derived MSCs

DLX3 Mutation Negatively Regulates Odontogenic Differentiation of Human Dental Pulp Cells.

Senescence: Novel Insight into DLX3 Mutations Leading to Enhanced Bone Formation in Tricho-Dento-Osseous Syndrome

Effects of DLX3 on the Osteogenic Differentiation of Induced Pluripotent Stem Cell‑derived Mesenchymal Stem Cells.

DLX3 Epigenetically Regulates Odontoblastic Differentiation of Hdpcs Through H19/miR-675 Axis

DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis

Mutant Dlx3b Disturbs Normal Tooth Mineralization and Bone Formation in Zebrafish

Mir-675 Promotes Odontogenic Differentiation of Human Dental Pulp Cells by Epigenetic Regulation of DLX3

DNA damage-inducible transcript 3 restrains osteoclast differentiation and function

NDR2 is Critical for the Osteoclastogenesis by Regulating ULK1-mediated Mitophagy.

Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene

NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis

MicroRNA-197-3p Inhibits the Osteogenic Differentiation in Osteoporosis by Down-Regulating KLF 10

Lncrna Expression Profiles and the Negative Regulation of Lncrna-Nommut037835.2 in Osteoclastogenesis.

Transcriptional Factor Dlx3 Promotes The Gene Expression Of Enamel Matrix Proteins During Amelogenesis

A Novel DLX3 Mutation Causes Tricho-Dento-osseous Syndrome with Abnormal Enamel Structure and Formation.

Mir-664-3p Suppresses Osteoblast Differentiation And Impairs Bone Formation Via Targeting Smad4 And Osterix

TGF-Β3 Restrains Osteoclastic Resorption Through Autophagy